Literature DB >> 35978742

An Unusual Case of Drug-Induced Liver Injury Secondary to Nitrofurantoin Use.

Stephen Wonnacott1, Dhir Gala1, Mili Shah1, Diksha Kaul2, Vikash Kumar2.   

Abstract

Nitrofurantoin is a commonly prescribed antibiotic for uncomplicated urinary tract infections. Despite a number of side effects, it is increasingly prescribed due to its low cost, high efficacy, and minimal antimicrobial resistance. One of the rare, however significant side effects of nitrofurantoin is idiosyncratic drug-induced liver toxicity. It commonly presents with abdominal pain and elevated liver enzymes. Interestingly, it can cause either an acute or a chronic hepatitis-like syndrome that can be severe and lead to liver failure or cirrhosis. We present a case of a healthy 24-year-old female who presented with epigastric abdominal pain, which was found to be drug-induced liver injury (DILI) secondary to her recent nitrofurantoin use.
Copyright © 2022, Wonnacott et al.

Entities:  

Keywords:  drug reaction; drug-induced liver injury; liver; nitrofurantoin; transaminitis

Year:  2022        PMID: 35978742      PMCID: PMC9375953          DOI: 10.7759/cureus.26882

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  16 in total

1.  Drug-induced autoimmune hepatitis: clinical characteristics and prognosis.

Authors:  Einar Björnsson; Jayant Talwalkar; Sombat Treeprasertsuk; Patrick S Kamath; Naoki Takahashi; Schuyler Sanderson; Matthias Neuhauser; Keith Lindor
Journal:  Hepatology       Date:  2010-06       Impact factor: 17.425

2.  Autoimmune-like drug-induced liver injury: a review and update for the clinician.

Authors:  Jonathan G Stine; Patrick G Northup
Journal:  Expert Opin Drug Metab Toxicol       Date:  2016-07-21       Impact factor: 4.481

Review 3.  Nitrofurantoin-induced hepatotoxicity: a rare yet serious complication.

Authors:  Sami A Sakaan; Jennifer D Twilla; Justin B Usery; John C Winton; Timothy H Self
Journal:  South Med J       Date:  2014-02       Impact factor: 0.954

Review 4.  Long-term hepatic memory for hypersensitivity to nitrofurantoin.

Authors:  L A Paiva; P J Wright; R S Koff
Journal:  Am J Gastroenterol       Date:  1992-07       Impact factor: 10.864

Review 5.  Nitrofurantoin revisited: a systematic review and meta-analysis of controlled trials.

Authors:  Angela Huttner; Els M Verhaegh; Stephan Harbarth; Anouk E Muller; Ursula Theuretzbacher; Johan W Mouton
Journal:  J Antimicrob Chemother       Date:  2015-06-11       Impact factor: 5.790

6.  Nitrofurantoin-induced acute liver damage in pregnancy.

Authors:  Alenka Aksamija; Gordana Horvat; Dubravko Habek; Damir Zalac; Eva Jendris
Journal:  Arh Hig Rada Toksikol       Date:  2009-09       Impact factor: 1.948

7.  Nitrofurantoin: mechanism of action and implications for resistance development in common uropathogens.

Authors:  C C McOsker; P M Fitzpatrick
Journal:  J Antimicrob Chemother       Date:  1994-05       Impact factor: 5.790

8.  HLA associations with autoimmune-type chronic active hepatitis: identification of B8-DRw3 haplotype by family studies.

Authors:  I R Mackay; B D Tait
Journal:  Gastroenterology       Date:  1980-07       Impact factor: 22.682

9.  Mitigation of nitrofurantoin-induced toxicity in the perfused rat liver.

Authors:  W Shen; B Hoener
Journal:  Hum Exp Toxicol       Date:  1996-05       Impact factor: 2.903

10.  Features of Autoimmune Hepatitis in Patients With Drug-induced Liver Injury.

Authors:  Ynto S de Boer; Andrzej S Kosinski; Thomas J Urban; Zhen Zhao; Nanye Long; Naga Chalasani; David E Kleiner; Jay H Hoofnagle
Journal:  Clin Gastroenterol Hepatol       Date:  2016-06-14       Impact factor: 11.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.